Sales and Marketing

Showing 15 posts of 11524 posts found.

New clinical trial testing diabetes drug for reducing risk of Alzheimer’s

December 13, 2021 Sales and Marketing

A new study run by the Diabetes Trials Unit, and the Department of Psychiatry at the University of Oxford, alongside …

UK government sets new booster target

December 13, 2021 Sales and Marketing

The PM has announced that booster jabs will be offered to everyone over 18 in England from this week, and …

Feedback receives funding for cloud-based tuberculosis programme

December 13, 2021 Sales and Marketing

Specialist clinical communication company, Feedback, announced that it has partnered with Amazon Web Services (AWS) to establish and deliver cloud-based …

Maintaining product authenticity: The solution to a serial problem

December 6, 2021 Sales and Marketing

Counterfeit medicines pose a serious risk to public safety, and, in some cases, can lead to serious adverse effects (SAE) …

Sidelined or streamlined? Diabetic care and COVID-19

December 6, 2021 Sales and Marketing

The worldwide restrictions put in place as a result of COVID-19 have necessitated innovation in multiple medical spheres. Diabetes, which …

TIB Molbiol develops test kits for Omicron variant detection

December 6, 2021 Sales and Marketing

TIB Molbiol, a newly acquired subsidiary of Roche, has developed three new VirSNiP test kits for the detection of mutations …

FDA grants Lilly’s COVID-19 antibody therapy EUA for paediatric use

December 6, 2021 Sales and Marketing

Eli Lilly has been granted an expanded Emergency Use Authorisation (EUA) for its neutralising antibody treatment, based on the safety …

J&J COVID-19 booster shows increase in antibody and T-cell responses, in Phase II trial

December 6, 2021 Sales and Marketing

Johnson & Johnson have announced positive results from an independent Phase II study, which reveal that a booster shot of …

Vaccine makers pledge to develop Omicron-effective jab

November 29, 2021 Sales and Marketing

Leading vaccine producers have shared that they are already pursuing vaccine responses to the newly-discovered coronavirus variant, Omicron. BioNTech has …

Nottinghamshire school sets up targeted testing for Omicron

November 29, 2021 Sales and Marketing

A school in Nottingham has set up targeted testing after a case of the new COVID-19 variant, Omicron, was detected …
mufid-majnun-oi20ehignd4-unsplash

WHO: unclear if Omicron causes severe disease

November 29, 2021 Sales and Marketing

WHO has shared that it is still unclear whether the recently-detected coronavirus variant Omicron is more transmissible, or causes more …

FDA approves AI-based breast cancer screening software MammoScreen®

November 29, 2021 Sales and Marketing

The FDA has approved MammoScreen®, Therapixel’s explainable and actionable Artificial Intelligence (AI) based software assisting Radiologists in breast cancer screening. …

FDA approves Pfizer and Moderna boosters for all US adults

November 22, 2021 Sales and Marketing

The FDA and CDC have cleared the Pfizer and Moderna booster jabs for adults, after reviewing new data supporting the …

FDA accept New Drug Application for Obseva’s linzagolix

November 22, 2021 Sales and Marketing

Obseva, a biopharmaceutical company developing and commercialising novel therapies to improve reproductive health, have announced that the NDA for linzagolix …

Novel mechanisms could transform standards of care in multiple cancers, MS, and Lupus

November 22, 2021 Sales and Marketing

Leading science and technology company, Merck KGaA, Darmstadt, Germany have identified five mid- to late-stage assets with first-in-class potential for …
The Gateway to Local Adoption Series

Latest content